1 Introduction Cholestatic liver diseases are a leading indication for pediatric liver transplantation (LT) and encompass a diverse group of disorders that impair bile formation or flow, resulting in the accumulation of bile constituents within the liver [1]. This process causes progressive hepatocellular injury, inflammation, and fibrosis, ultimately leading to cirrhosis, portal hypertension, and end-stage liver disease [2, 3].
Thomas Cotter
As seen in:
Medium,
Wiley Online Library,
OUPblog,
Gut Journal,
MDPI,
The Hill,
Law360,
JD Supra,
Lexology,
Washington and Lee Law Review
and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Thomas Cotter
Integrating Phosphatidylethanol to Enhance Alcohol Quantification in Steatotic Liver Disease and Clinical Trials
AEs adverse events ALD alcohol-associated liver disease ALT alanine aminotransferase AST aspartate aminotransferase AUD alcohol use disorder AUDIT-C alcohol use disorders identification test–consumption CDT carbohydrate-deficient transferrin CMRFs cardiometabolic risk factors EtG ethyl glucuronide EtS ethyl sulfate FAEEs fatty acid ethyl esters FGF21 fibroblast growth factor 21 GGT gamma-glutamyl transferase GLP-1 RAs glucagon-like peptide-1 receptor agonists LT liver transplantation MASLD...
Client Alert: The One Big Beautiful Bill: Major Tax Reforms That Could Reshape Your Planning | JD Supra
The One Big Beautiful Bill (OBBB), signed into law on July 4, 2025, introduced major changes impacting individual, estate, state, local, real estate, and business tax rules. Understanding these updates is key for tax planning. Business Provisions Exclusion of Gain on the Sale or Exchange of Qualified Small Business Stock (QSBS).
Letter: Addressing the Growing Disparities in Alcohol‐Associated Liver Disease—A Call for Equitable Healthcare Strategies: Authors' Reply
On behalf of our coauthors, we appreciate the insightful commentary by El-Kassas et al. on our study examining disparities among a diverse Texas-based alcohol-associated liver disease (ALD) inpatient cohort [1]. Their letter highlights important social and biological contributors to these disparities, which merit further exploration [2]. El-Kassas et al.
Disparities in Alcohol‐Associated Liver Disease Hospital Encounters Amongst a Texas‐Based Cohort of Patients
1 Introduction Alcohol-associated liver disease (ALD) has become the leading cause of mortality from liver disease and the leading indication for liver transplantation (LT) in the United States (U.S.) [1, 2]. Increased amounts of alcohol consumption amongst the population has resulted in an increase burden of both alcohol use disorder (AUD) and ALD.
Nov. 14 Webinar on German FRAND Cases and Related Developments
I will be moderating the event described in this announcement: Join us for "German FRAND Cases: The EC’s Amicus Brief and Other Developments" on Thursday, November 14, 2024, | 15:00 (Central European Time) | 14:00 (Greenwich Time) | 9:00 a.m. (U.S. Central Time) This one-hour webinar will focus on the developing German case law concerning FRAND-committed standard-essential patents (SEPs); the possible impact of the European Commission’s amicus brief in the pending HMD Global Oy v.
Donle on the European Commission’s Amicus Brief
Christian Donle has published a short piece titled Amicus Curiae-Eingabe der Kommission zu standardessenziellen Patenten (“Amicus Curiae Brief of the Commission on Standard-Essential Patents”), 19/2024 GRUR 1404-05.Here is the abstract (my translation): The Commission has submitted an amicus curiae brief in two parallel SEP infringement proceedings with the Munich Higher Regional Court, and explained its understanding of the CJEU’s decision in Huawei v.
EWCA: Xiaomi Entitled to Interim FRAND License to Panasonic SEPs
This morning the Court of Appeal for England and Wales released its decision in Panasonic Holdings Corp. v.
Racial, Ethnic, and Socioeconomic Disparities in Access to Critical Procedures in Patients Hospitalized with Cirrhosis Complications
Preprint Article Version 1 This version is not peer-reviewed Version 1 : Received: 18 September 2024 / Approved: 18 September 2024 / Online: 18 September 2024 (15:30:12 CEST) Sanchez, M. M.; Sabillon, C. A.; Cotter, T. G.; Mayo, M. J.; Sanchez, K. A.; Egwim, C.; Aashish, A. Racial, Ethnic, and Socioeconomic Disparities in Access to Critical Procedures in Patients Hospitalized with Cirrhosis Complications. Preprints 2024, 2024091425. https://doi.org/10.20944/preprints202409.1425.v1 Sanchez, M.
Upcoming Speaking Engagement on Injunctions
I will be one of the panelists at an upcoming webinar hosted by the Federalist Society, titled Patent Owners in the Soup... No Injunction for You! The event will take place on Thursday, August 25 at 11 a.m. Eastern. Jeffrey Depp will moderate; the other speakers will be Jonathan Barrett, Nicholas Matich, and Paul Michel. More information is available here.
Upcoming Webinar on German SEP Litigation
As I have mentioned previously, Peter Picht, Erik Habich, and I have an edited volume that will be published in the coming weeks, titled FRAND: German Case Law and Global Perspectives (Edward Elgar Publishing).The volume includes seven chapters providing a comprehensive look at the issues the German courts have addressed in FRAND cases, and an additional eight chapters composed of essays by each of us and by leading judges and scholars.(A draft of the first seven (case law) chapters is on...
From Around the Blogs: Injunctions
There have been several posts over the past few weeks about injunctions: 1.On the Kluwer Patent Blog, Claire Phipps-Jones published The Future of UK PIs—Cyanamid, Skat and injunction creep, discussing recent English case law emphasizing the importance of preserving the status quo, at least for relatively short periods of time, even where there are no unusual obstacles to quantifying the parties’ interim harm and there are doubts about patent validity.Ms. Phipps-Jones also published, on the...
Federal Circuit: No Awards for Fees Incurred in IPRs
Florian Mueller beat me to this one (see here).The Federal Circuit held this morning in Dragon Intellectual Property LLC v.
Comparative Patent Remedies
1.On EPLaw, Sarah Taylor and Stefan van Kolfschooten published a post titled UPC—10x Genomics v.
Today Is The Blog's 11th Anniversary
I completely forgot until just now—I launched this blog on May 6, 2013, exactly eleven years ago today. I'm happy to say that I plan to continue doing this indefinitely. I hope my readers continue to find it a useful resource.
CJEU Grand Chamber to Hear Argument Concerning Cross-Border Relief
Last week, Florian Mueller published a post on his new site ipfray, titled Grand Chamber of European Court of Justice takes patent case—question of cross-border jurisdiction.The case at issue is BSH Haugeräte GmbH v. Electrolux AB, and although the questions referred date back to May 2022 and the case has already been heard by a regular chamber, the CJEU’s decision to assign the matter to a “Grand Chamber” of fifteen judges is recent.
Comparative Patent Remedies
1. Enrico Bonadio and Dyuti Pandya recently published a post on the Kluwer Patent Blogtitled China’s Supreme People Court decides FRAND dispute in ACT v Oppo.The post links to several other sources discussing the SPC’s December 2023 decision in this case, previously noted here, includingMA Butian, Second-instance judgment in ACT v Oppo sheds light on comparable agreements and how to find fault in SEP licensing negotiations, Global Competition Review, Feb.
Federal Circuit Affirms Award of No Damages, Vacates Denial of Permanent Injunction
The case is In re California Expanded Metal Products Co., nonprecedential opinion by Judge Taranto, joined by Judges Dyk and Mayer.According to the opinion, California Expanded Metal Products Co. (CEMCO) “is the current owner of the five patents at issue in this case,” which “generally describe and claim fire-retardant assemblies for the top of a wall, the assemblies including an intumescent strip that seals construction joints or gaps when exposed to heat” (p.2).“At the time of trial, there...
Stief on Preliminary Injunctions Prior to Grant
The issue of whether courts in EPO member states have authority to grant preliminary injunctions on the basis of pending patent applications has recently been litigated in a number of European countries (see previous mentions on this blog here, here, here, and here). Marco Stief has now published two papers, one in German and one in English, on the topic, noting that such injunctions appear to be permissible in some countries, albeit in several of them only in exceptional cases.
The UPC’s October 10, 2023 Decision in 10x Genomics
This may be less consequential now than it may have seemed a couple of weeks ago, before the UPC Court of Appeals decision referenced here, but readers may recall that there was a second decision last fall in which the Munich Local Division considered a preliminary injunction against Nanostring. As far as I can tell, the second decision (dated Oct. 10, 2023)—which, in contrast to the first (Sept.
Cotter and Shen on Destruction and Proportionality
My article with Professor Chung-Lun Shen, Destruction, Proportionality, and Sustainability: A Law-and-Economics Analysis, 32 Texas Intellectual Property Law Journal 111 (2024), has now been published.It is available on Westlaw and SSRN, and should be available soon on TIPLJ’s website.Here is the abstract: This Paper undertakes a law-and-economics analysis of the remedy of destruction (and, subsidiarily, the related remedies of recall and removal) of products that infringe intellectual...
Federal Circuit Vacates Preliminary Injunction
I am a little late reporting on this one. The case is UATP IP, LLC v.
Court of Appeal of the Unifed Patent Court Reverses Preliminary Injunction Against Nanostring
I just read this report on JUVE Patent about the UPC Court of Appeals' reversal of the Munich Local Division's much-discussed September 19, 2023 grant of a preliminary injunction in favor of 10x against Nanostring. (For previous discussion on this blog, see here.) Here is a link to the relevant UPC webpage, with links to the decision in German and in English.
Montefusco and Crespo on Spanish Eli Lilly v. Teva Decision
A post I published a few months ago titled Recent Patent Damages Decision of the Madrid Court of Appeal began as follows: A few weeks back Adrián Crespo published a short post on the Kluwer Patent Blog titled Patent case: Judgment no.
Benzinga APIs 2023 Year in Review
As we start 2024, Benzinga APIs would like to share with you what we have accomplished this past year. 2023 has been a year of remarkable achievements for us. From enhancing our product suite to forging new partnerships, we’ve made strides in shaping the future of financial data services. On the product side, we’ve made some considerable improvements to our existing product suite as well as developed some new display and alternative data products listed below.
JCM | Free Full-Text | Comparing High- and Low-Model for End-Stage Liver Disease Living-Donor Liver Transplantation to Determine Clinical Efficacy: A Systematic Review and Meta-Analysis (CHALICE Study)
Altmetric announcement Help format_quote Cite thumb_up ... Endorse Need Help? Find support for a specific problem in the support section of our website. Please let us know what you think of our products and services. Visit our dedicated information section to learn more about MDPI.
Bears Say: Analyst Ratings Summaries Made Easy
Investing in the stock market can be a daunting task, especially when it comes to interpreting analyst ratings and research reports. The abundance of information and the use of industry jargon often make it challenging for investors to grasp the true sentiment behind these reports. But fear not! We have just launched an API product called Bulls Say / Bears Say that aims to simplify this process and empower investors with actionable insights.
Government Trades API is Live!
Closing the Information Gap: We're thrilled to introduce you to our latest offering: Government Trades data. Enhancing Transparency and Accountability: Benzinga's Government Trades API aims to bridge this gap by offering comprehensive and up-to-date data on the trading activities of U.S. politicians.
How does JWT Authentication work?
We're happy to announce that Benzinga APIs now support JWT authentication! So what is a JWT? JSON web tokens (JWTs) are an increasingly popular method for securely transmitting information between parties. In this blog post, we'll take a closer look at how JWTs work and why they are becoming a go-to solution for web developers. It is commonly used in the context of authentication and authorization for APIs, where it provides a simple and secure way to represent the claims of a user.
Optis v. Apple, Nokia v. OPPO, and the Risk of Judicial Error
Law-and-economics literature talks a lot about the risk of error, including the risk of judicial error, as a reason for or against various rules and standards.Error costs, for example, are a standard consideration in the law-and-economics analysis of property rules versus liability rules, as I have discussed, e.g., here.Outside of antitrust law, however, where the balancing of type I (false positive) and type II (false negative) errors has become something of a commonplace, you don’t see...
Loconsole on a Recent Italian Patent Damages Decision
This decision--Cappellotto S.p.A v. Farid Industrie S.p.A., Cassazione civile sez. I - 02/03/2021, n. 5666-- was previously discussed by Giulia Pasqualetto and Federica Franchetti on EPLaw (in both a short post a longer, four-page write-up), as I noted here. It is now also the subject of a short article by Michele Loconsole, Reasonable Royalty and "Adequate" Compensation for Patent Infringement: Italian Supreme Court, No. 5666/2021, 43 E.I.P.R. 752-54 (2021).
Recent Papers on FRAND Issues and Dispute Resolution
1. Jorge Contreras has posted on ssrn a short paper titled Anti-Suit Injunctions and Jurisdictional Competition In Global FRAND Litigation: The Case For Judicial Restraint. Here is a link, and here is the abstract: The proliferation of international jurisdictional conflicts and competing “anti-suit injunctions” in litigation over the licensing of standards-essential patents has raised concerns among policy makers in the United States, Europe and China.
DOJ Antitrust Division Economics Director of Enforcement Jeffrey Wilder on SEPs
Jeffrey Wilder, the U.S. Department of Justice Antitrust Division Economics Director of Enforcement, gave a speech yesterday before the IAM and GCR Connect SEP Summit in Washington. Here is a link to the text, which I perceive as a welcome return to sanity.
Federal Circuit Reaffirms That Section 287 Requires Actual Notice of the Infringement
In a precedential decision handed down last week, Lubby Holdings LLC v. Chung, a panel of the Federal Circuit reaffirmed the long-standing interpretation the the patent marking statute, 35 U.S.C. § 287(a), precludes an award of damages for infringing conduct pre-dating the defendant's receipt of either actual notice of the infringement or, though marking, constructive notice.
Thoughts on the U.K. Supreme Court's Decision in Servier
Last Friday I noted that the U.K. Supreme Court had issued its decision in Secretary of State for Health v. Servier Laboratories Ltd.,[2021] UKSC 24, and I said that I might have more to say about it in the next few days. Lord Hamblen's opinion strikes me as very well-reasoned, so I don't have a lot to say, but here goes. The case involves an action for "unlawful means" brought by the U.K. Secretary of State of Health, as successor in interest to various National Health Service bodies.
Transparency More Crucial Than New FRAND Royalty Methods
Law360 (June 14, 2021, 5:42 PM EDT) -- In the cases to date in which courts have had to determine the fair, reasonable and nondiscriminatory royalties due for the infringement of FRAND-committed standard-essential patents,[1] they generally have applied one or both of two competing methodologies.
Comparative Patent Remedies
See post on FOSS Patents here. So presumably we won't be getting a Federal Circuit decision on the anti-antisuit injunction issue in this case.
Breaking News: Biden Administration to Support TRIPS COVID Waiver
See here, and stories on Bloomberg, the New York Times, the Wall Street Journal, and the Washington Post. It remains to be seen what the final deal will look like, and there will certainly be a lot more coverage from other sources in the hours and days to come.
Shenzhen Court to Set Global FRAND Rate
I learned this morning that the Shenzhen Intermediate People's Court has announced that it will determine a global FRAND rate in a dispute between Sharp and Oppo, apparently at the request of the implementer (Oppo). Reports by Michael Renaud, James Wodarski, and Mathew Galica are available on National Law Review and also here, and also a story by Bing Zhao is said to be available on IAM here (behind a paywall, so I haven't been able to access this myself).
French Court Awards Record Damages Judgment
The case is Eli Lilly v. Fresenius Kabi, Tribunal Judiciare de Paris, 11 Sept. 2020, Docket No. 17/10421, and the award comes to €28,000,000. Pierre Véron recently published a post on the decision EPLaw, with links to his more extended commentary and copies of the judgment in the original French and in English translation. As he points out, this is one of many European decisions involving Lilly's patents on the use of pemetrexed disodium for treatment of lung cancer.
UK Top Court Ruling May Be Problematic For Global SEP Suits
By Thomas Cotter (September 21, 2020, 3:39 PM EDT) -- On Aug. 26, the U.K. Supreme Court handed down its long-awaited decision in the joined cases of Unwired Planet International Ltd. v. Huawei Technologies (UK) Co. Ltd.; Huawei Technologies Co. Ltd. v. Conversant Wireless Licensing SÀRL.; and ZTE Corp. v.
Halo Seeks to Recover Extraterritorial Damages from Pulse
Some readers may be aware that I've been working on a paper titled Extraterritorial Damages in Patent Law. I haven't posted it yet on ssrn, but the basic argument is that, both as a matter of legal doctrine (post-WesternGeco v.
An Automated Inpatient Split-dose Bowel Preparation Improves Colonoscopy Preparation Quality
Background Inpatient colonoscopy bowel preparation is frequently inadequate, negatively impacting patient safety and procedure quality, directly leading to higher costs due to prolonged hospital stays. At the University of Chicago Medical Center (UCMC), inpatient bowel preparation ordering had not previously been standardized, which led to practice variability and suboptimal results.
License To All Should Prevail In FRAND Patent Wars
Law360 (June 4, 2020, 2:14 PM EDT) -- Complex products such as smartphones and automobiles incorporate numerous components made by different firms within a supply chain. These individual components, in the aggregate, may incorporate thousands of patented features, many of which are essential to the practice of technical standards that enable end products to communicate with one another.
Client Alert: How Employers May Defer Social Security Tax Payments Under Section 2302 of the CARES Act | JD Supra
Updated: May 25, 2018: JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.
Client Alert: Treasury Delays Federal Income Tax Filing and Payment Deadlines | Lexology
On March 20, 2020, the Internal Revenue Service (“IRS”) released Notice 2020-18 which delays the due date for the filing of federal income tax returns and federal income tax payments due April 15, 2020 until July 15, 2020. Earlier in the week, the IRS had issued Notice 2020-17, which put caps on the payment amounts that could be delayed for different categories of taxpayers and kept the April 15, 2020 filing deadline in place.
Gov't Policy Statement On SEP Remedies Should Be Cabined
Law360 (January 6, 2020, 12:53 PM EST) -- A little over a year ago, Makan Delrahim, the assistant attorney general for the Antitrust Division of the U.S. Department of Justice, announced the division’s withdrawal from the U.S. Patent and Trademark Office and DOJ's 2013 Policy Statement on Remedies for Standards-Essential Patents Subject to Voluntary F/RAND Commitments.[1] More recently, USPTO Director Andre Iancu signaled that his office likely would follow suit,[2] and so it came as no...
Huawei Case Might Mean UK Forum Sets Global FRAND Rates
Law360 (October 2, 2019, 3:44 PM EDT) -- For four days beginning Oct. 21, the U.K. Supreme Court will hear arguments in the joined cases of Unwired Planet International Ltd. v. Huawei Technologies Co. Ltd., Huawei Technologies v. Conversant Wireless Licensing SARL, and ZTE Corp. v.
2 Themes From Qualcomm’s Appeal Of FTC's Antitrust Win
Law360 (September 5, 2019, 10:16 AM EDT) -- In May, Judge Lucy Koh of the U.S. District Court for the Northern District of California issued her 233-page findings of fact and conclusions of law in the landmark antitrust case Federal Trade Commission v.
Gastric volvulus involving the duodenum
Gastric volvulus involving the duodenum Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. Copyright information: © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Thomas
Contact Thomas, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack